Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma

Respiratory Medicine

Volumn 107, Issue 3, 2013, Pages 347-354

  Nie, Hanxiang ^a   Zhang, Guqin ^b   Liu, Min ^a   Ding, Xuhong ^a   Huang, Yi ^a   Hu, Suping ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Airway inflammation; Asthma; Salmeterol fluticasone propionate combination product; Small airway function; Theophylline

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL PLUS THEOPHYLLINE; PLACEBO; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; CLINICAL ASSESSMENT TOOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; EOSINOPHIL COUNT; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CIRCADIAN RHYTHM; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; RESPIRATORY MECHANICS; SPUTUM; THEOPHYLLINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874695271     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.12.004     Document Type: Article

References (27)

1. Global Strategy or Asthma Management and Prevention. Global initiative for asthma (GINA) (revised 2009). Available from: http://www.ginasthma.org.
2. M.L. Levy, M. Thomas, I. Small, L. Pearce, H. Pinnock, and P. Stephenson Summary of the 2008 BTS/SIGN British Guideline on the management of asthma Prim Care Respir J 18 2009 S1 S16
3. National Asthma Education and Prevention Program Expert panel report 3 (EPR3): guidelines for the diagnosis and management of asthma-summary report 2007 J Allergy Clin Immunol 120 2007 S94 S138
4. E.D. Bateman, H.A. Boushey, and J. Bousquet Can guideline-defined asthma control be achieved? The gaining optimal asthma control study Am J Respir Crit Care Med 170 2004 836 844
5. K.F. Rabe, M. Adachi, and C.K. Lai Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol 114 2004 40 47
6. E.R. McFadden Jr. Methylxanthines in the treatment of asthma: the rise, the fall, and the possible rise again Ann Intern Med 115 1991 323 324
7. C.G. Persson, and A.B. Draco Xanthines as airway anti-inflammatory drugs J Allergy Clin Immunol 81 1988 615 617
8. P. Sullivan, S. Bekir, Z. Jaffar, C. Page, P. Jeffery, and J. Costello Anti-inflammatory effects of low-dose oral theophylline in atopic asthma Lancet 343 1994 1006 1008
9. J. Kidney, M. Dominguez, P.M. Taylor, M. Rose, K.F. Chung, and P.J. Barnes Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy Am J Respir Crit Care Med 151 1995 1907 1914
10. D.J. Evans, D.A. Taylor, O. Zetterstrom, K.F. Chung, B.J. O'Connor, and P.J. Barnes A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma N Engl J Med 337 1997 1412 1418
11. D. Ukena, U. Harnest, and R. Sakalauskas Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma Eur Respir J 10 1997 2754 2760
12. R.A. Nathan, C.A. Sorkness, and M. Kosinski Development of the Asthma Control Test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65
13. N. Ringdal, A. Eliraz, and R. Pruzinec The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma Respir Med 97 2003 234 241
14. N. Hanxiang, Y. Jiong, and C. Yanwei Persistent airway inflammation and bronchial hyperresponsiveness in patients with totally controlled asthma Int J Clin Pract 62 2008 599 605
15. K. Gendo, and M.J. Lodewick Asthma economics: focusing on therapies that improve costly outcomes Curr Opin Pulm Med 11 2005 434 450
16. M.K. Tulic, and Q. Hamid New insights into the pathophysiology of the small airways in asthma Clin Chest Med 27 2006 41 52
17. Q. Hamid, Y. Song, and T.C. Kotsimbos Inflammation of small airways in asthma J Allergy Clin Immunol 100 1997 44 51
18. I.H. van Veen, P.J. Sterk, R. Schot, S.A. Gauw, K.F. Rabe, and E.H. Bel Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma Eur Respir J 27 2006 951 956
19. C. Bergeron, H.P. Hauber, and M. Gotfried Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide J Allergy Clin Immunol 116 2005 983 989
20. M. Kraft The distal airways: are they important in asthma? Eur Respir J 14 1999 1403 1417
21. M.K. Tulic, P. Christodoulopoulos, and Q. Hamid Small airway inflammation in asthma Respir Res 2 2001 333 339
22. P.R. Burgel The role of small airways in obstructive airway diseases Eur Respir Rev 20 2011 23 33
23. D.C. Grootendorst, J.K. Sont, and L.N. Willems Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies Clin Exp Allergy 27 1997 769 779
24. I.D. Pavord, M.M. Pizzichini, E. Pizzichini, and F.E. Hargreave The use of induced sputum to investigate airway inflammation Thorax 52 1997 498 501
25. C. Leach, G.L. Colice, and A. Luskin Particle size of inhaled corticosteroids: does in matter? J Allergy Clin Immunol 124 2009 S88 S93
26. P. Howarth Small airway inflammation and asthma Int J Clin Pract Suppl 96 1998 15 22
27. S. Makino, M. Fueki, and N. Fueki Efficacy and safety of methylxanthines in the treatment of asthma Allergol Int 53 2004 13 22